January 31, 2018
Teikoku Pharma agreed Wednesday not to engage in pay-for-delay deals with generic-drug makers in an injunction that ends accusations by attorneys general in California, Delaware, Florida, Illinois and 18 other states that the Japanese drugmaker obstructed generic competition for its pain relief patch Lidoderm.